IKK alpha, actif, humain étiqueté GST, PRECISIO Kinase, recombinant, exprimé en cellules bactériulovirus infectées Sf9, > = 70% (SDS-PAGE), solution aqueuse tamponnée de glycérol

Code: srp5040-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

IKKA is a serine/threonine protein kinase that phosphorylates the I-kappa-B protein which is an inhibitor of the transcription factor NF-kappa-B complex. ...


en savoir plus

Votre prix
£469.00 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

IKKA is a serine/threonine protein kinase that phosphorylates the I-kappa-B protein which is an inhibitor of the transcription factor NF-kappa-B complex. Phosphorylation of I-kappa-B protein triggers the degradation of the inhibitor via the ubiquitination pathway, thereby activating NF-kappa-B complex. IKKA is an essential regulator of NF-kappa-B-dependent gene expression through control of promoter-associated histone phosphorylation after cytokine exposure. IKKA is a critical component of the cytoplasmic transductional-transcriptional processor leading to induction of IFNA production. IKKA is also involved in the epidermis where it antagonizes mitogenic and angiogenic signals and represses tumor progression and metastases.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol.

Preparation Note

after opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... CHUK(1147)
mol wt~114 kDa
NCBI accession no.BC092514
product linePRECISIO® Kinase
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity2.1-2.9 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: